• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

2019 年冠状病毒病大流行前后川崎病发病率降低的区域性差异。

Regional Differences in Kawasaki Disease Incidence Reduction Before and After the Onset of the Coronavirus Disease 2019 Pandemic.

机构信息

Department of Pediatrics, Shiga University of Medical Science, Shiga, Japan.

National Institute of Technology, Gifu College, Gifu, Japan.

出版信息

J Pediatr. 2022 Nov;250:54-60.e5. doi: 10.1016/j.jpeds.2022.07.008. Epub 2022 Jul 16.

DOI:10.1016/j.jpeds.2022.07.008
PMID:35850239
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9287537/
Abstract

OBJECTIVE

To assess regional differences in reduction of the incidence of Kawasaki disease during the mitigation period for the coronavirus disease 2019 pandemic, with a hypothesis that more sparsely populated regions have fewer opportunities for human-to-human contact, resulting in a greater reduction in the incidence of Kawasaki disease.

STUDY DESIGN

A retrospective ecological study was conducted using data from patients hospitalized for Kawasaki disease as well as infectious diseases surveillance reports in Shiga Prefecture, Japan, during 2015-2020. We defined the periods before and after the onset of pandemic as January 2015-March 2020 and as April 2020-December 2020, respectively. We compared the reductions in the incidence of Kawasaki disease among 6 administrative regions in the prefecture according to the density of the populations.

RESULTS

A total of 1290 patients with Kawasaki disease were identified. The incidence of Kawasaki disease (per 100 000 person-years) was significantly reduced after the coronavirus disease 2019 pandemic onset (period before pandemic onset, 105.6 [95% CI 99.8-111.8]; period after pandemic onset, 68.6 [95% CI 56.7-83.0]). During the period after pandemic onset, the incidence of Kawasaki disease was significantly reduced in May, compared with the corresponding period in previous years. The number of patients aged 2-4 years was significantly reduced after the pandemic onset. Notably, greater reductions in the incidence of Kawasaki disease were found in regions with lower population densities.

CONCLUSIONS

Assuming that there were fewer opportunities for human-to-human contact in more sparsely populated regions during the pandemic mitigation period, our findings support the hypothesis that human-to-human contact may be associated with development of Kawasaki disease.

摘要

目的

评估 2019 年冠状病毒病大流行缓解期间川崎病发病率降低的区域差异,假设人口密度较低的地区人与人之间接触的机会较少,导致川崎病发病率降低幅度更大。

研究设计

采用日本滋贺县川崎病住院患者及传染病监测报告数据进行回顾性生态学研究,将 2015 年至 2020 年期间分为大流行前(2015 年 1 月至 2020 年 3 月)和大流行后(2020 年 4 月至 2020 年 12 月)两个时期。根据人口密度比较该县 6 个行政区川崎病发病率的降低情况。

结果

共纳入 1290 例川崎病患者。川崎病发病率(每 10 万人年)在冠状病毒病 2019 大流行后显著降低(大流行前时期为 105.6[95%CI 99.8-111.8];大流行后时期为 68.6[95%CI 56.7-83.0])。大流行后时期,5 月川崎病发病率较往年同期显著降低。发病年龄 2-4 岁患者人数在大流行后显著减少。值得注意的是,人口密度较低的地区川崎病发病率降低幅度更大。

结论

假设大流行缓解期间人口密度较低的地区人与人之间接触的机会较少,我们的研究结果支持人与人之间接触可能与川崎病发病相关的假设。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d764/9287537/966b083130ea/fx2_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d764/9287537/82c52ccd01f8/gr1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d764/9287537/2306b4781d0b/gr2_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d764/9287537/ea017f8e8a64/fx1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d764/9287537/966b083130ea/fx2_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d764/9287537/82c52ccd01f8/gr1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d764/9287537/2306b4781d0b/gr2_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d764/9287537/ea017f8e8a64/fx1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d764/9287537/966b083130ea/fx2_lrg.jpg

相似文献

1
Regional Differences in Kawasaki Disease Incidence Reduction Before and After the Onset of the Coronavirus Disease 2019 Pandemic.2019 年冠状病毒病大流行前后川崎病发病率降低的区域性差异。
J Pediatr. 2022 Nov;250:54-60.e5. doi: 10.1016/j.jpeds.2022.07.008. Epub 2022 Jul 16.
2
Prevention Measures for COVID-19 and Changes in Kawasaki Disease Incidence.COVID-19 的预防措施与川崎病发病率变化。
J Epidemiol. 2021 Nov 5;31(11):573-580. doi: 10.2188/jea.JE20210132. Epub 2021 Sep 17.
3
Kawasaki Disease and Pediatric Infectious Diseases During the Coronavirus Disease 2019 Pandemic.川崎病与 2019 冠状病毒病疫情期间的儿科传染性疾病。
J Pediatr. 2021 Dec;239:50-58.e2. doi: 10.1016/j.jpeds.2021.07.053. Epub 2021 Jul 26.
4
Incidence of Kawasaki Disease Before and After the COVID-19 Pandemic in Japan: Results of the 26th Nationwide Survey, 2019 to 2020.日本 COVID-19 大流行前后川崎病的发病率:2019 至 2020 年第 26 次全国调查结果。
JAMA Pediatr. 2022 Dec 1;176(12):1217-1224. doi: 10.1001/jamapediatrics.2022.3756.
5
Kawasaki disease before and during the COVID-19 pandemic: a single-center comparative study in Switzerland.川崎病在 COVID-19 大流行前后:瑞士单中心比较研究。
BMC Pediatr. 2024 Oct 8;24(1):637. doi: 10.1186/s12887-024-05115-0.
6
Emergence of Kawasaki disease related to SARS-CoV-2 infection in an epicentre of the French COVID-19 epidemic: a time-series analysis.新冠疫情期间法国疫区出现与 SARS-CoV-2 感染相关的川崎病:时间序列分析。
Lancet Child Adolesc Health. 2020 Sep;4(9):662-668. doi: 10.1016/S2352-4642(20)30175-9. Epub 2020 Jul 2.
7
Incidence of Kawasaki disease before and during the COVID-19 pandemic: a retrospective cohort study in Japan.川崎病在 COVID-19 大流行前后的发病率:日本的一项回顾性队列研究。
BMJ Paediatr Open. 2021 Apr 2;5(1):e001034. doi: 10.1136/bmjpo-2021-001034. eCollection 2021.
8
Kawasaki Disease Before and During the COVID-19 Pandemic: A Nationwide Population-based Study in the United States.川崎病在 COVID-19 大流行前后:美国的一项全国基于人群的研究。
Pediatr Infect Dis J. 2024 Jan 1;43(1):7-13. doi: 10.1097/INF.0000000000004095. Epub 2023 Sep 7.
9
Changes in the Clinical Characteristics of Kawasaki Disease After Coronavirus Disease (COVID-19) Pandemic: A Database Analysis.COVID-19 大流行后川崎病临床特征的变化:数据库分析。
J Korean Med Sci. 2022 May 23;37(20):e141. doi: 10.3346/jkms.2022.37.e141.
10
Novel coronavirus infection and Kawasaki disease.新型冠状病毒感染与川崎病。
J Matern Fetal Neonatal Med. 2022 Aug;35(16):3044-3048. doi: 10.1080/14767058.2020.1800633. Epub 2020 Jul 30.

引用本文的文献

1
Decreased incidence of Kawasaki disease in South Korea during the SARS-CoV-2 pandemic.韩国在新冠病毒大流行期间川崎病发病率下降。
Front Pediatr. 2024 Apr 3;12:1307931. doi: 10.3389/fped.2024.1307931. eCollection 2024.
2
Kawasaki Disease Before and During the COVID-19 Pandemic: A Nationwide Population-based Study in the United States.川崎病在 COVID-19 大流行前后:美国的一项全国基于人群的研究。
Pediatr Infect Dis J. 2024 Jan 1;43(1):7-13. doi: 10.1097/INF.0000000000004095. Epub 2023 Sep 7.

本文引用的文献

1
Temporal clustering of Kawasaki disease cases around the world.全球川崎病病例的时间聚集性。
Sci Rep. 2021 Nov 19;11(1):22584. doi: 10.1038/s41598-021-01961-5.
2
An Unintended Consequence of Pandemic Control Measures: Fewer Cases of Kawasaki Disease.疫情防控措施的一个意外后果:川崎病病例减少。
J Pediatr. 2021 Dec;239:11-14. doi: 10.1016/j.jpeds.2021.08.069. Epub 2021 Aug 26.
3
Kawasaki Disease and Pediatric Infectious Diseases During the Coronavirus Disease 2019 Pandemic.川崎病与 2019 冠状病毒病疫情期间的儿科传染性疾病。
J Pediatr. 2021 Dec;239:50-58.e2. doi: 10.1016/j.jpeds.2021.07.053. Epub 2021 Jul 26.
4
Reduction in Kawasaki Disease After Nonpharmaceutical Interventions in the COVID-19 Era: A Nationwide Observational Study in Korea.新冠疫情时代非药物干预后川崎病发病率的下降:韩国一项全国性观察性研究
Circulation. 2021 Jun 22;143(25):2508-2510. doi: 10.1161/CIRCULATIONAHA.121.054785. Epub 2021 Jun 7.
5
Identification of a shared genetic risk locus for Kawasaki disease and immunoglobulin A vasculitis by a cross-phenotype meta-analysis.通过跨表型荟萃分析鉴定川崎病和免疫球蛋白 A 血管炎的共享遗传风险位点。
Rheumatology (Oxford). 2022 Mar 2;61(3):1204-1210. doi: 10.1093/rheumatology/keab443.
6
Incidence of Kawasaki disease before and during the COVID-19 pandemic: a retrospective cohort study in Japan.川崎病在 COVID-19 大流行前后的发病率:日本的一项回顾性队列研究。
BMJ Paediatr Open. 2021 Apr 2;5(1):e001034. doi: 10.1136/bmjpo-2021-001034. eCollection 2021.
7
The Impact of Social Distancing for COVID-19 Upon Diagnosis of Kawasaki Disease.社交隔离对 COVID-19 患儿川崎病诊断的影响。
J Pediatric Infect Dis Soc. 2021 Aug 14;10(6):742-744. doi: 10.1093/jpids/piab013.
8
The impact of COVID-19 lockdown on infectious diseases epidemiology: The experience of a tertiary Italian Pediatric Emergency Department.COVID-19 封锁对传染病流行病学的影响:意大利一家三级儿科急诊部的经验。
Am J Emerg Med. 2021 May;43:115-117. doi: 10.1016/j.ajem.2021.01.065. Epub 2021 Jan 27.
9
Bronchiolitis in COVID-19 times: a nearly absent disease?新冠时期的细支气管炎:一种近乎缺失的疾病?
Eur J Pediatr. 2021 Jun;180(6):1969-1973. doi: 10.1007/s00431-021-03968-6. Epub 2021 Jan 30.
10
Assessment of 135 794 Pediatric Patients Tested for Severe Acute Respiratory Syndrome Coronavirus 2 Across the United States.美国对 135794 名儿科患者进行严重急性呼吸综合征冠状病毒 2 检测的评估。
JAMA Pediatr. 2021 Feb 1;175(2):176-184. doi: 10.1001/jamapediatrics.2020.5052.